SEC Filing Summary for Edesa Biotech, Inc.

This filing details a grant of 19,000 restricted share units to Sean Arthur MacDonald, a director at Edesa Biotech, Inc. The grant was made under the company's 2019 Equity Incentive Compensation Plan. These units will vest in equal proportions over twelve months, starting from the grant date. The transaction, which occurred on May 27, 2026, is reported with a transaction price of $0.00, as indicated by footnote F1, suggesting it was an equity award. Following this transaction, Mr. MacDonald holds 41,054 shares, with ownership nature designated as direct (D). The filing, document type 4, was signed on May 29, 2026.